160 related articles for article (PubMed ID: 16844734)
1. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
[TBL] [Abstract][Full Text] [Related]
2. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
Ma D; Liu X; Cai Z; Xie Q
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
[TBL] [Abstract][Full Text] [Related]
3. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
Ma DL; Liu XH; Bai CG; Xie Q; Feng F
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
[TBL] [Abstract][Full Text] [Related]
5. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
[TBL] [Abstract][Full Text] [Related]
7. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of c-kit oncogene in gastrointestinal stromal tumors].
Liu X; Ma D; Wu L; Bai C; Hu H
Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):277-9. PubMed ID: 12133359
[TBL] [Abstract][Full Text] [Related]
9. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
Zhao P; Hou N; Shao Y; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors.
Yamaguchi M; Tate G; Endo Y; Miyaki M
Hepatogastroenterology; 2003; 50(53):1431-5. PubMed ID: 14571755
[TBL] [Abstract][Full Text] [Related]
13. C-kit expression and mutational analysis in medulloblastoma.
Chilton-Macneill S; Ho M; Hawkins C; Gassas A; Zielenska M; Baruchel S
Pediatr Dev Pathol; 2004; 7(5):493-8. PubMed ID: 15547773
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
[TBL] [Abstract][Full Text] [Related]
15. Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors.
Kikuchi H; Yamamoto M; Hiramatsu Y; Baba M; Ohta M; Kamiya K; Tanaka T; Suzuki S; Sugimura H; Kitagawa M; Kanai T; Kitayama Y; Kanda T; Nishikura K; Konno H
Cancer Sci; 2007 Nov; 98(11):1734-9. PubMed ID: 17894554
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
Matsui K; Jin XM; Kitagawa M; Miwa A
Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
[TBL] [Abstract][Full Text] [Related]
18. C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis.
Tayal S; Classen E; Bemis L; Robinson WA
Anticancer Res; 2005; 25(3B):2215-20. PubMed ID: 16158966
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
